MESOBLAST LTD
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
Other share classesMEOBF
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
72
- +3 vs. Q1 2026
- Total value $53.3M
Superinvestors holding MESO
0
- None of the superinvestors held MESO at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MESO insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 4 – Apr 10, 2026 | George GregoryDirector, 10% Owner | PPurchaseOrdinary Shares | +7.91M | $1.4407 | +$11.4M | 8.32M | +1,915.0% | SEC |
| Apr 10, 2026 | Apr 4 – Apr 10, 2026 | George GregoryDirector, 10% Owner | PPurchaseOrdinary Shares | +8.31M | $3.1465 | +$26.14M | 8.32M | +45,864.0% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MESO at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MORGAN STANLEY | 718,608 | $9.72M | 0.00% | +204,177+39.7% | Added |
| BlackRock, Inc. | 664,280 | $8.99M | 0.00% | +33,425+5.3% | Added |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 457,744 | $6.19M | 0.01% | +71,272+18.4% | Added |
| GOLDMAN SACHS GROUP INC | 395,612 | $5.35M | 0.00% | −1,603−0.4% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 259,700 | $3.51M | 0.00% | +259,700 | New |